Search Ontology:
ChEBI

dihydroergotamine

Term ID
CHEBI:4562
Synonyms
  • (10alphaH)-5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman
  • 5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman
  • 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione
  • 9,10-dihydroergotamine
  • dihidroergotamina
  • Dihydroergotamine
  • dihydroergotaminum
Definition
Ergotamine in which a single bond replaces the double bond between positions 9 and 10. A semisynthetic ergot alkaloid with weaker oxytocic and vasoconstrictor properties than ergotamine, it is used (as the methanesulfonic or tartaric acid salts) for the treatment of migraine and orthostatic hypotension.
References
  • beilstein:78887
  • cas:511-12-6
  • drugbank:DB00320
  • drugcentral:888
  • kegg.compound:C07798
  • kegg.drug:D07837
  • knapsack:C00001724
  • lincs.smallmolecule:LSM-3619
  • pubmed:10954953
  • pubmed:20132337
  • pubmed:8145914
  • wikipedia.en:Dihydroergotamine
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
Phenotype
Phenotype resulting from dihydroergotamine
Phenotype where environments contain dihydroergotamine
Phenotype modified by environments containing dihydroergotamine
Phenotype affecting dihydroergotamine
Human Disease Model